Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 13, 2016
Certara®, a provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, has announced that Peking Union Medical College (PUMC) Hospital in Beijing, China, and Keio University in Tokyo...
read more
Thursday, October 13, 2016
Veeva Systems has expanded its leadership team across product management and cloud software development to accelerate innovation and customer success in clinical operations and data management. Veeva is bringing together established industry experts...
read more
Thursday, October 13, 2016
Aptuit has relocated its recently acquired subsidiary Kuecept to its Oxford UK site, and added further formulation and safety assessment capacity to meet sustained customer demand for IND de-risking and enabling packages.
read more
Wednesday, October 12, 2016
Recipharm, the contract development and manufacturing organization (CDMO), has launched a showcase line for serialization, offering pharmaceutical companies the chance to view and trial its solution to the new European and US regulations.
read more
Wednesday, October 12, 2016
Marken announced the opening of a new depot and logistics operation in Argentina, which will replace the current location. The new location is larger, more modern and will expand its capabilities in the region.
read more
Wednesday, October 12, 2016
Teligent, a New Jersey-based specialty generic pharmaceutical company, has opened a pharmaceutical Product Development laboratory in Estonia.
read more
Wednesday, October 12, 2016
UK-based Sterling Pharma Solutions has formed as an independent contract development and manufacturing organisation (CDMO) following a management buyout (MBO) of the UK based Dudley site.
read more
Wednesday, October 12, 2016
Nitto Denko Avecia Inc. has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals, both located in Irvine, CA.
read more
Wednesday, October 12, 2016
Daiichi Sankyo Company, Limited and the Dana-Farber Cancer Institute have announced a preclinical research collaboration focused on lung cancer.
read more
Teva Pharmaceutical Industries has agreed to sell assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Limited (a subsidiary of Intas Pharmaceuticals Ltd) for an agreed value of GBP 603 million, subject to final ...
read more
PAREXEL International Corporation has announced the launch of its Active Tracking service. The service follows Good Distribution Practice (GDP) requirements by providing biopharmaceutical companies with near real-time temperature and location ...
read more
Evotec AG has announced that in line with its strategy to participate in promising corporate formations it will deepen its already existing relationship with Carrick. Evotec will invest up to $ 6 m towards Carrick's latest funding round.
read more
WuXi AppTec (WuXi), recently opened their new 150,000-square-foot biomanufacturing facility in an event attended by Pennsylvania Lieutenant Governor Mike Stack and WuXi AppTec Chairman and Chief Executive Officer, Dr. Ge Li. The new facility is WuXi...
read more
Envirotainer has announced that Debbie Ng has joined Envirotainer as the new Head of Operations APAC at its new operation center in Singapore. This is part of Envirotainer’s strategy to help strengthen its support in the region.
read more
Tuesday, October 04, 2016
Ajinomoto Althea, Inc. (“Althea”) announced that a biologics candidate developed by a Japanese global pharmaceutical company and manufactured at Ajinomoto Althea using CORYNEX® Protein Expression System, has entered phase I clinical trials.
read more